Vega eliminates challenges associated with conventional handheld ultrasound systems, PerkinElmer said. The company gained the Vega technology with the acquisition of SonoVol.

The Vega ultrasound platform comes with two automated transducers and does not require a sonographer. Key features include brightness and motion modes, acoustic angiography mode for visualization of microvasculature, and shear wave elastography mode to measure and evaluate tissue stiffness.

Vega's widefield imaging enables researchers to visualize the pathophysiology of diseases such as cancer, liver and kidney disease, and cardio diseases, Perkin Elmer said.

PerkinElmer introduces new ChemDraw v.21 software
PerkinElmer has launched ChemDraw v.21 software for the import, animation, creation and sharing of 3D chemical structures intrinsically in the Microsoft...

PerkinElmer, Centre for Genomic Regulation partner on diabetes gene therapy
PerkinElmer's Sirion Biotech and the Centre for Genomic Regulation entered into an agreement to jointly develop new generation adeno-associated virus...

PerkinElmer highlights new workflows at SLAS 2022
BOSTON - Following a series of acquisitions of Horizon Discovery, BioLegend, Nexcelom Bioscience, and Omni International in 2021, PerkinElmer showcased...

Carterra, PerkinElmer sign distribution agreement for antibody solutions
Carterra has signed an exclusive Asia-Pacific and Oceania region distribution agreement with PerkinElmer. According to the agreement, PerkinElmer will...